Vanessa Sansone
Discovery at UTSA

Changing Our World

Vanessa Sansone

Changing Our World

A roundup of some of the most important research and events news from across the university

SHARE THIS

STORY HIGHLIGHTS

  • Educational leadership professor is honored by a national education publication.
  • Researcher earns NSF grant to study ubiquitous sensing and computing technologies.
  • A group of UTSA researchers aims to pave the way for new tuberculosis treatments.

Posted 09/01/2020 |
FROM THE FALL/WINTER 2020 ISSUE

EQUITY ADVOCATE: Vanessa A. Sansone [above], assistant professor of educational leadership and policy studies, was named to the 2020 class of leading women in higher education by Diverse: Issues in Higher Education. She was selected for exhibiting extraordinary leadership skills and advancing equity and success for Latinx students, first-generation students, low-income students, student veterans, and rural students.


SENSOR SECURITY: UComputer science professor Murtuza Jadliwala has been awarded a $499,512 grant from the National Science Foundation to fund his research on securing modern ubiquitous sensing and computing technologies, such as mobile, wearable, and internet-of-things systems, against private data inference and exfiltration threats.


STUDYING SPREAD: UTSA researchers have uncovered evidence about the importance of maintaining physical distance to minimize the spread of microbes by studying wild colobus monkeys in Ghana. Anthroplogy professor Eva Wikberg and her team studied the fecal matter of 45 female monkeys that congregated in eight different social groups and found that microbes may be transmitted during occasional encounters with members of other social groups.


TB TREATMENT: A group of UTSA researchers is interested in paving the way for new tuberculosis treatments to improve upon current drugs that can have adverse side effects. Under the direction of biochemistry professor Aimin Lu, the Metalloprotein Research Laboratory is learning more about the qualities of an enzyme called CYP121. If the understanding of CYP121 can be improved, better tuberculosis drugs can be designed to decrease side effects.